Cited by 413Angiogenesis and VEGF in CancerMesenchymal stem cell researchNitric Oxide and Endothelin Effects

Endothelial progenitor cells in cardiovascular disorders

Open access
Shantsila, Eduard, Watson, Timothy, Lip, Gregory Y.H.·2007·Journal of the American College of Cardiology

Abstract

The important role of the vascular endothelium in cardiovascular health is increasingly recognized. However, mature endothelial cells possess limited regenerative capacity. There is therefore much interest in circulating endothelial progenitor cells (EPCs) among the scientific community, especially into their purported role in maintenance of endothelial integrity and function, as well as postnatal neovascularization. It has been suggested that these cells might not only be responsible for the continuous recovery of the endothelium after injury/damage, but also might take part in angiogenesis, giving the hope of new treatment opportunities. Indeed, there is accumulating evidence showing reduced availability and impaired EPC function in the presence of both cardiovascular disease and associated comorbid risk factors. Thus, many studies into the potential for use of EPCs in the clinical setting are being undertaken. The goal of this review article is to provide an overview of data relevant to the clinical role of EPCs and perspectives for treatment of cardiovascular disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2006.09.050

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

2 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells through cell fusion, but not transdifferentiation. Nat Med 2004;10:494 -501.
  2. Stamm C, Westphal B, Kleine H-D, et al. Autologous bone marrow transplantation for myocardial regeneration. Lancet 2003;361:45-6.

Cited by

Sorted by citations

Authors
Shantsila, E., Watson, T., & Lip, G. Y. H.
Affiliations
Birmingham City Hospital (GB)
Corresponding author
Lip, Gregory Y.H.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2007-02
Volume
49
Issue
7
Pages
741-752
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2025299174
Cited by
413
References
127
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 14 · 2017: 22 · 2016: 19 · 2015: 25 · 2014: 36 · 2013: 21 · 2012: 41
FWCI
3.31
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Sandwell and West Birmingham Hospitals NHS Trust
  • European Society of Cardiology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
endothelial progenitor cells, cardiovascular disease, vascular endothelium, re-endothelialization, angiogenesis, neovascularization, endothelial dysfunction, cardiovascular risk factors, cell therapy
MeSH terms
Aging, Animals, Cardiovascular Agents, Cardiovascular Diseases, Disease Models, Animal, Humans, Risk Factors, Stem Cells, Treatment Outcome, Neovascularization, Physiologic, Stem Cell Transplantation, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review